LVE:PA:PA-Lyxor UCITS Stoxx 50 Daily Leverage (EUR)

ETF | Others |

Last Closing

USD 63.83

Change

-0.10 (-0.16)%

Market Cap

USD 0.13B

Volume

8.50K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-25 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.40 (+0.86%)

USD 55.36B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-10.50 (-1.83%)

USD 14.29B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-7.62 (-1.85%)

USD 13.82B
WRD:PA HSBC MSCI World UCITS ETF

-0.56 (-1.52%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-0.12 (-0.05%)

USD 9.11B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-14.30 (-2.84%)

USD 8.85B
WLD:PA Lyxor UCITS MSCI World D-EUR

-5.44 (-1.50%)

USD 7.99B
HHH:PA HSBC S&P 500 UCITS ETF

-1.05 (-1.81%)

USD 7.71B
LCWD:PA Multi Units Luxembourg - Lyxor..

N/A

USD 6.91B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

+0.13 (+1.68%)

USD 5.25B

ETFs Containing LVE:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 22.84% 99% N/A 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.84% 99% N/A 94% A
Trailing 12 Months  
Capital Gain 23.44% 89% A- 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.44% 88% B+ 86% B+
Trailing 5 Years  
Capital Gain 135.45% 97% N/A 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 135.45% 97% N/A 93% A
Average Annual (5 Year Horizon)  
Capital Gain 28.61% 94% A 90% A-
Dividend Return 28.61% 94% A 95% A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 32.99% 56% F 63% D
Risk Adjusted Return 86.71% 81% B- 89% A-
Market Capitalization 0.13B 34% F 49% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.